Although SERT deficiency, either by genetic deletion or pharmacological inhibition is associated with obesity and associated metabolic diseases in human and animal models8–10, 36, the molecular factors mediating SERT deficiency-associated obesity and related metabolic disorder remains poorly understood. This evidence concerns the gene SLC6A4 and metabolic disease.